Evidence map›Paper›PMID 29026272›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2017

Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS).

Susumu Yokoya, Tomonobu Hasegawa, Keiichi Ozono, Hiroyuki Tanaka, Susumu Kanzaki, Toshiaki Tanaka, Kazuo Chihara, Nan Jia, Christopher J Child, Katsuichiro Ihara and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially?Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2018
    Article
  3. Responses to the Letter to the Editor "Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?" (Vol. 27, No. 2, p. 107-108, 2018).Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Susumu YokoyaDepartment of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
Tomonobu HasegawaDepartment of Pediatrics, School of Medicine, Keio University, Tokyo, Japan.
Keiichi OzonoDepartment of Pediatrics, Graduate School of Medicine, Osaka University, Osaka, Japan.
Hiroyuki TanakaDepartment of Pediatrics, Okayama Saiseikai General Hospital, Okayama, Japan.
Susumu KanzakiDivision of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Tottori, Japan.
Toshiaki TanakaTanaka Growth Clinic, Tokyo, Japan.
Kazuo ChiharaHyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan.
Nan JiaLilly Research Laboratories, Eli Lilly and Company, Indiana, USA.
Christopher J ChildLilly Research Laboratories, Eli Lilly and Company, Windlesham, UK.
Katsuichiro IharaMedical Science, Eli Lilly Japan K.K., Kobe, Japan.
Jumpei FunaiScientific Communications, Eli Lilly Japan K.K., Kobe, Japan.
Noriyuki IwamotoMedical Science, Eli Lilly Japan K.K., Kobe, Japan.
Yoshiki SeinoJCHO Osaka Hospital, Osaka, Japan.
Eli Lilly (Japan) · JPEli Lilly (United Kingdom) · GBEli Lilly (United States) · USKeio University · JPNational Center For Child Health and Development · JPOkayama Saiseikai General Hospital · JPOsaka Hospital · JPOsaka University · JPTanaka Holdings (Japan) · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary goal of the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) was to assess the safety and effectiveness of Humatrope

Indexed as

diabetes mellitusneoplasiapediatric GH treatmentsafetyshort stature

Identifiers

PMID29026272
PMCPMC5627224
OpenAlexW2759206151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.